Skip to content
PeptideRank

Provider review

Tryozi review

Names four pharmacies and their 503A category in one sentence.

Its own Terms page states, "Licensed U.S. 503A compounding pharmacies: RedRock, Health Warehouse, Precision Medicine, Triad Rx" — a genuine same-citation match, though the featured price is a first-month-only discount at half the standing rate.

Verified August 2026

Transparency scorecard

3 of 4 disclosed openly

What Tryozi discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Disclosed

Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.

State coverage published

Disclosed

Publishes which states it actually serves.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainly some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

What it actually costs

Medium confidence

What they advertise

Tryozi's own homepage states, on one line: "Semaglutide Injection... $139 $279/mo First month 50% off — $139 for your first 4 weeks, then $279/mo" and "Tirzepatide Injection... $189 $379/mo First month 50% off — $189 for your first 4 weeks, then $379/mo."

What you actually pay, month to month

$279/mo (semaglutide) and $379/mo (tirzepatide) are Tryozi's own stated standing rates, disclosed on the same homepage line as the first-month discount — "then $279/mo" / "then $379/mo," not hidden on a separate page.

The commitment trap

The featured, largest-type price ($139/$189) is explicitly a first-4-weeks-only discount, clearly labeled "First month 50% off" on the same line as the standing rate — the real ongoing rate is exactly double ($279/mo semaglutide, $379/mo tirzepatide).

Checked live on Tryozi's own site at https://www.tryozi.com/ in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off Tryozi's own public pages on the date shown, not from a third-party comparison table.

The bottom line

Tryozi (tryozi.com, legal entity Tryozi Group LLC, Pembroke Pines, FL) is a real, live telehealth platform selling compounded semaglutide and compounded tirzepatide. Its own Terms page names four specific 503A pharmacies directly in the same sentence as the regulatory category — "Licensed U.S. 503A compounding pharmacies: RedRock, Health Warehouse, Precision Medicine, Triad Rx" — a cleaner same-citation match than most peers on this roster, which typically name either a pharmacy or a category, not both together. Its own homepage states a specific "all 50 states + D.C." claim and is LegitScript-certified. The gap is the featured price: the largest-type, first-seen figure on the homepage ("$139" semaglutide, "$189" tirzepatide) is explicitly a first-4-weeks-only discount, stated on the same line as the real standing rate ($279/mo, $379/mo) — exactly double. Two of its four named pharmacies, Triad Rx and Precision Medicine, are also named by other providers on this roster flagged elsewhere for a dedicated FDA-letter/fraud-pattern check — not itself disqualifying, since sharing a fulfillment pharmacy is not evidence of fraud by Tryozi, but worth the same direct fda.gov check before treating this row as fully cleared.

Tryozi appears on our tirzepatide provider ranking and our semaglutide provider ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want a specific pharmacy tied directly to a stated 503A category in the same sentence — Tryozi names four, together, on one page.
  • You've read past the featured first-month price to the standing rate shown on the same line, and are comfortable with $279-379/mo ongoing.
  • You want a specific "all 50 states + D.C." claim rather than a bare "nationwide" claim.

Look elsewhere if

  • You're budgeting off the featured "$139"/"$189" price without reading the rest of the line — that figure is a first-4-weeks-only discount; the standing rate, stated immediately beside it, is exactly double ($279/mo semaglutide, $379/mo tirzepatide).
  • You want independent reassurance about its fulfillment pharmacies before signing up — two of its four named pharmacies overlap with ones flagged elsewhere on this roster for a dedicated FDA-letter check.
  • You want a dietitian, nurse, or structured coaching program bundled into the price — none is named anywhere on the site.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what Tryozi bundles in, and what it does not.

Clinician consult

Included, per its own homepage (licensed-clinician review is…

bundled into the price).

Bloodwork / labs

"Base labs included"

— standard labs via Quest or Labcorp — stated directly on the homepage.

Follow-ups and dose changes

"Ongoing dose adjustments" stated directly on the homepage…

("Your clinician titrates and adjusts as you go").

Human support

No dietitian, nurse, or structured coaching program is named…

anywhere on the site.

Injection supplies

"Medication + shipping" is stated as included on the homepage.

Shipping

Included, per the homepage's "Medication + shipping" line.

Who fills it, and who's watching

The pharmacy

503A, named four times in one sentence. Its own Terms page states directly, "Licensed U.S. 503A compounding pharmacies: RedRock, Health Warehouse, Precision Medicine, Triad Rx."

Oversight

Included, per its own homepage (licensed-clinician review is bundled into the price). "Ongoing dose adjustments" stated directly on the homepage ("Your clinician titrates and adjusts as you go").

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.

Where you can get it

A clean, specific claim: its own homepage states, "Available in all 50 states + D.C."

The honest cons

The part they would rather you skipped

The featured, largest-type price on Tryozi's own homepage ("$139" semaglutide, "$189" tirzepatide) is explicitly a first-4-weeks-only discount — the real standing rate, stated on the same line, is exactly double ($279/mo, $379/mo); a reader who doesn't finish the sentence could reasonably mistake the discount for the ongoing price.

  • The featured price is a first-4-weeks-only discount at half the real standing rate, though both figures appear on the same line, not on separate pages.
  • Two of its four named pharmacies (Triad Rx, Precision Medicine) are also named by other providers on this roster flagged elsewhere for a dedicated FDA-letter/fraud-pattern check.
  • No dietitian, nurse, or structured coaching program is named anywhere on the site.

None of this is unique to Tryozi — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect Tryozi's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Tryozi's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.